Back

Combined SGLT2 inhibition and GLP-1 receptor agonism synergistically reduce rejection-associated oxidative stress in cardiac allografts of heart transplant recipients

30 August 2026 (14:39 - 14:57)
Organised by: Logo
Congress Presentation Part of: Preventing heart failure Heart Failure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ali Mroueh

Strasbourg (France)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on preventing heart failure
Professor B. Ibanez (Madrid, ES)
Slides
Presentation thumbnail
Fbxo7 stabilizes PHGDH to maintain cardiac serine metabolism and prevent heart failure
Doctor Y. Gong (Hangzhou, CN)
Abstract Slides
Presentation thumbnail
Paracrine fibroblast–endothelial dialogue promotes pulmonary vascular remodeling in cardiometabolic HFpEF
Doctor M. Telesca (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Preventing heart failure
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 14:39 CET
You may be interested in
thumbnail
Congress Presentation
The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers
27 August 2021
thumbnail
Congress Presentation
Factors associated with the cardiac allograft vasculopathy after heart transplantation
1 September 2020
thumbnail
Congress Presentation
Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction
29 August 2020
thumbnail
Congress Presentation
Expanding frontiers in cardiometabolic therapy: SGLT2 inhibitors and GLP-1 receptor agonists
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources